Dallah to hit record revenue, profit in 2025: Chairman

Tarek Alkasabi, Chairman of Dallah Healthcare Co.

Dallah Healthcare Co. entered the final quarter of 2025 on solid footing, Chairman Tarek Alkasabi said, expecting it to be the strongest-performing quarter of the year, as expansion projects progress and operational efficiency continues to improve.

In an interview with Argaam, Alkasabi said the company’s performance during the first nine months of 2025 was encouraging, particularly after expanding in the Eastern Province through the acquisition of Dallah Al Khobar and Dallah Al Ahsa hospitals.

The two hospitals are expected to generate revenue exceeding SAR 500 million, surpassing earlier projections.

The growth prospects remain strong across the company’s facilities, the Chairman said, highlighting Dallah Al Khobar Hospital as one of the most promising. The company succeeded in reducing the hospital’s losses by 95% during the current quarter, while continuing to expand its operating capacity and services.

He expressed confidence in the hospital’s bright future in serving patients in the Eastern Province.

Alkasabi affirmed that these factors collectively support the company’s optimistic outlook for 2025, which is expected to be another record year for Dallah in terms of revenue, profit, and medical achievements.

The total patient visits across the company’s facilities rose by more than 35% year-on-year in Q3 2025, across both outpatient and inpatient services, the Chairman addded, noting that the growth was driven by the addition of the two newly acquired hospitals, while pre-acquisition facilities saw a healthy 9% rise in outpatient visits.

Moreover, he explained that the 12.5% increase in Q3 net profit was mainly due to revenue growth and a 17.8% rise in gross profit, equivalent to SAR 58 million compared to a year earlier.

He noted that, following the acquisition of Al Salam Hospital, the company leveraged its strong financial position to renegotiate the terms of its long-term Murabaha financing, lowering funding costs and recording SAR 29.5 million in remeasurement gains in Q3 2025.

The Chairman added that losses at Dallah Al Khobar Hospital were significantly reduced, with net losses falling by SAR 44 million, or 95%, compared to the same period last year. He explained that the comparative quarter’s losses were not consolidated as they preceded the acquisition.

The sharp reduction in losses resulted from higher patient volumes and improved operational efficiency, noting that Dallah Al Khobar remains in its early operational stages, offering strong potential for future financial and service growth.

According to Argaam data, Dallah Healthcare Co.’s profit rose to SAR 421.7 million for the first nine months of 2025, with Q3 profit reaching SAR 141.9 million.

The total patient visits across the company’s facilities rose by more than 35% year-on-year in Q3 2025, across both outpatient and inpatient services, the Chairman addded, noting that the growth was driven by the addition of the two newly acquired hospitals, while pre-acquisition facilities saw a healthy 9% rise in outpatient visits.

Moreover, he explained that the 12.5% increase in Q3 net profit was mainly due to revenue growth and a 17.8% rise in gross profit, equivalent to SAR 58 million compared to a year earlier.

He noted that, following the acquisition of Al Salam Hospital, the company leveraged its strong financial position to renegotiate the terms of its long-term Murabaha financing, lowering funding costs and recording SAR 29.5 million in remeasurement gains in Q3 2025.

The Chairman added that losses at Dallah Al Khobar Hospital were significantly reduced, with net losses falling by SAR 44 million, or 95%, compared to the same period last year. He explained that the comparative quarter’s losses were not consolidated as they preceded the acquisition.

The sharp reduction in losses resulted from higher patient volumes and improved operational efficiency, noting that Dallah Al Khobar remains in its early operational stages, offering strong potential for future financial and service growth.

According to Argaam data, Dallah Healthcare Co.’s profit rose to SAR 421.7 million for the first nine months of 2025, with Q3 profit reaching SAR 141.9 million.